How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Weil Gotshal law firm plans to dissolve, capping dizzying fall Weil, Gotshal & Manges plans to wind down its operations, its leadership told partners on Wednesday, capping a dizzying downfall for the ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...